A Study on Two Adjuvant Trials in Patients With Stage III Colon Cancer

July 16, 2015
Frank A. Sinicrope, MD

Frank A. Sinicrope, MD, medical oncologist, Departments of Gastroenterology and Hepatology and Oncology, Cancer Center, Mayo Clinic discusses a study on two adjuvant trials in patients with stage III colon cancer.

Sinicrope and his team conducted the study in order to look at the association of overall survival with colon cancers that have deficient DNA mismatch repair. Both large adjuvant trials were randomized, and they were conducted within the United States and Europe.

Frank A. Sinicrope, MD, medical oncologist, Departments of Gastroenterology and Hepatology and Oncology, Cancer Center, Mayo Clinic discusses a study on two adjuvant trials in patients with stage III colon cancer.